ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,477.90
0.16%
US Tech 100
19,132.80
-0.22%
다우존스 지수
39,127.80
0.04%
Bitcoin
60,807.97
-1.62%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 영국
  5. LSE
  6. Regeneron Pharmaceuticals Inc (0R2M)

  7. Regeneron Pharmaceuticals Inc (0R2M) 뉴스

0R2M

Regeneron Pharmaceuticals (0R2M)

Regeneron Pharmaceuticals Inc
일자:
정렬 기준:
 검색 관련기사 보기:LSE:0R2M
일자시간출처헤드라인심볼기업
2024/01/2706:07Alliance NewsAlliance NewsSanofi and Regeneron celebrate Dupixent's FDA approvalLSE:0R2MRegeneron Pharmaceuticals Inc
2023/12/1204:25Alliance NewsAlliance NewsLeading pharmaceutical firms highlight positive trial data on lymphomaLSE:0R2MRegeneron Pharmaceuticals Inc
2022/09/1613:46Alliance NewsAlliance NewsRegeneron, Sanofi drug effective for young children with severe eczemaLSE:0R2MRegeneron Pharmaceuticals Inc
2022/09/0914:40Alliance NewsAlliance NewsRegeneron shares surge on positive Eylea trial dataLSE:0R2MRegeneron Pharmaceuticals Inc
2022/06/0223:18Alliance NewsAlliance NewsSanofi grants Regeneron global license for cancer treatment LibtayoLSE:0R2MRegeneron Pharmaceuticals Inc
2022/05/3114:54Alliance NewsAlliance NewsUS FDA accepts Regeneron and Sanofi's Dupixent for priority reviewLSE:0R2MRegeneron Pharmaceuticals Inc
2022/03/2814:18Alliance NewsAlliance NewsIN BRIEF: Sanofi, Regeneron hail positive results in prurigo nodularisLSE:0R2MRegeneron Pharmaceuticals Inc
2022/02/2815:21Alliance NewsAlliance NewsSanofi and Regeneron note positive new data for DupixentLSE:0R2MRegeneron Pharmaceuticals Inc
2022/02/1819:26Alliance NewsAlliance NewsRegeneron and Sanofi stop trial of skin condition treatment DupixentLSE:0R2MRegeneron Pharmaceuticals Inc
2022/01/1916:32Alliance NewsAlliance NewsSanofi and Regeneron's Dupixent meets endpoints for skin treatmentLSE:0R2MRegeneron Pharmaceuticals Inc
2021/11/1300:54Alliance NewsAlliance NewsTOP NEWS: Roche and Regeneron Covid antibody cocktail approved in EULSE:0R2MRegeneron Pharmaceuticals Inc
2021/10/2514:50Alliance NewsAlliance NewsSanofi and Regeneron's Dupixent trial meets primary endpointsLSE:0R2MRegeneron Pharmaceuticals Inc
2021/10/1421:18Alliance NewsAlliance NewsUS FDA accepts Regeneron's REGEN-COV application for priority reviewLSE:0R2MRegeneron Pharmaceuticals Inc
2021/09/3014:36Alliance NewsAlliance NewsRegeneron, Roche drug cocktail reduces Covid-19 viral load - UK studyLSE:0R2MRegeneron Pharmaceuticals Inc
2021/08/3015:23Alliance NewsAlliance NewsSanofi, Regeneron's Dupixent works for children with atopic dermatitisLSE:0R2MRegeneron Pharmaceuticals Inc
2021/07/2720:56Alliance NewsAlliance NewsAstraZeneca partners with Regeneron to research obesity treatmentLSE:0R2MRegeneron Pharmaceuticals Inc
2021/07/2014:58Alliance NewsAlliance NewsRoche and Regeneron's Covid antibody cocktail gets Japan approvalLSE:0R2MRegeneron Pharmaceuticals Inc
2021/06/2814:16Alliance NewsAlliance NewsSanofi, Regeneron report well-established safety profile of DupixentLSE:0R2MRegeneron Pharmaceuticals Inc
2021/06/2514:48Alliance NewsAlliance NewsSanofi and Regeneron's cancer treatment Libtayo gets approval in EULSE:0R2MRegeneron Pharmaceuticals Inc
2021/03/2316:26Alliance NewsAlliance NewsTOP NEWS: Novartis, Regeneron Covid antibody cocktail excels in trialsLSE:0R2MRegeneron Pharmaceuticals Inc
2021/03/1518:20Alliance NewsAlliance NewsRegeneron, Sanofi report positive phase three trial results of LibtayoLSE:0R2MRegeneron Pharmaceuticals Inc
2021/02/2702:25Alliance NewsAlliance NewsEU Medicines Regulator Approves Regeneron Coronavirus TherapyLSE:0R2MRegeneron Pharmaceuticals Inc
2021/02/2523:05Alliance NewsAlliance NewsRoche, Regeneron Note Positive Findings For REGEN-COV In Covid-19LSE:0R2MRegeneron Pharmaceuticals Inc
2021/02/2305:13Alliance NewsAlliance NewsIN BRIEF: Sanofi, Regeneron Get US FDA Approval For Lung Cancer DrugLSE:0R2MRegeneron Pharmaceuticals Inc
2021/01/1315:24Alliance NewsAlliance NewsRoche Says US To Buy Extra Doses Of Regeneron's Covid Antibody CoctailLSE:0R2MRegeneron Pharmaceuticals Inc
2020/12/0207:27Alliance NewsAlliance NewsRegeneron Pharmaceuticals Developing Nasal Spray To Prevent Covid-19LSE:0R2MRegeneron Pharmaceuticals Inc
2020/11/3018:59Alliance NewsAlliance NewsSanofi And Regeneron Announce New Dupixent Approval In ChildrenLSE:0R2MRegeneron Pharmaceuticals Inc
2020/10/2621:52Alliance NewsAlliance NewsSanofi, Regeneron Say Dupixent Lowers Esophagitis SymptomsLSE:0R2MRegeneron Pharmaceuticals Inc
2020/10/1622:19Alliance NewsAlliance NewsSanofi And Regeneron Get European Boost For DupixentLSE:0R2MRegeneron Pharmaceuticals Inc
2020/10/1314:35Alliance NewsAlliance NewsSanofi And Regeneron Say Dupixent Significantly Reduces Asthma AttacksLSE:0R2MRegeneron Pharmaceuticals Inc
 검색 관련기사 보기:LSE:0R2M

최근 히스토리

TG
PR1U
Amundi Luxembourg
LSE
SVC2
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유